CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 51 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $31,297,271 | +23.0% | 3,931,818 | 0.0% | 37.26% | -5.4% |
| Q3 2023 | $25,438,862 | +4.5% | 3,931,818 | 0.0% | 39.38% | +23.9% |
| Q2 2023 | $24,337,953 | +60.8% | 3,931,818 | 0.0% | 31.78% | +53.4% |
| Q1 2023 | $15,137,499 | +24.2% | 3,931,818 | 0.0% | 20.71% | +26.4% |
| Q4 2022 | $12,188,636 | -22.9% | 3,931,818 | 0.0% | 16.38% | +15.5% |
| Q3 2022 | $15,805,000 | -17.5% | 3,931,818 | 0.0% | 14.18% | -12.3% |
| Q2 2022 | $19,148,000 | -45.7% | 3,931,818 | 0.0% | 16.18% | -21.1% |
| Q1 2022 | $35,268,000 | -20.3% | 3,931,818 | 0.0% | 20.51% | +23.9% |
| Q4 2021 | $44,272,000 | -32.6% | 3,931,818 | 0.0% | 16.56% | -11.9% |
| Q3 2021 | $65,661,000 | -24.8% | 3,931,818 | 0.0% | 18.81% | -14.1% |
| Q2 2021 | $87,326,000 | – | 3,931,818 | – | 21.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,937,615 | $19,006,369 | 42.74% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129,161,626 | 41.24% |
| Vida Ventures Advisors, LLC | 3,931,818 | $25,438,862 | 39.38% |
| TCG Crossover Management, LLC | 2,040,816 | $13,204,079 | 1.94% |
| Affinity Asset Advisors, LLC | 1,018,091 | $6,587,049 | 1.85% |
| BVF INC/IL | 9,103,054 | $58,896,759 | 1.59% |
| Sio Capital Management, LLC | 756,891 | $4,897,085 | 1.52% |
| ACUTA CAPITAL PARTNERS, LLC | 323,349 | $2,092,068 | 1.40% |
| EcoR1 Capital, LLC | 5,618,779 | $36,353,500 | 1.23% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $62,641,362 | 0.97% |